Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug

Biotech's IPO summer isn't over yet. Electra Therapeutics plans to begin public trading on the Nasdaq after the Labor Day holiday, according to a Friday IPO filing with securities regulators. While ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Finance & Markets

More from Monday 31 August →